Telomerase reverse transcriptase gene knock‐in unleashes enhanced longevity and accelerated damage repair in mice
Aging Cell · 2025
DOI: 10.1111/acel.14445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Tian-Yi Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Longevity, Telomerase, Gene Knock-In Techniques. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Funding Supporting Projects of National Natural Science Foundation of China of NJUCM, Natural Science Foundation of the Jiangsu Higher Education Institutions of China, Open Project of State Key Laboratory of Natural Medicines.
Abstract (Originalsprache)
While previous research has demonstrated the therapeutic efficacy of telomerase reverse transcriptase (TERT) overexpression using adeno‐associated virus and cytomegalovirus vectors to combat aging, the broader implications of TERT germline gene editing on the mammalian genome, proteomic composition, phenotypes, lifespan extension, and damage repair remain largely unexplored. In this study, we elucidate the functional properties of transgenic mice carrying the Tert transgene, guided by precise gene targeting into the Rosa26 locus via embryonic stem (ES) cells under the control of the elongation factor 1α ( EF1α ) promoter. The Tert knock‐in ( TertKI ) mice harboring the EF1α‐Tert gene displayed elevated telomerase activity, elongated telomeres, and extended lifespan, with no spontaneous genotoxicity or carcinogenicity. The TertKI mice showed also enhanced wound healing, characterized by significantly increased expression of Fgf7, Vegf, and collagen. Additionally, TertKI mice exhibited robust resistance to the progression of colitis induced by dextran sodium sulfate (DSS), accompanied by reduced expression of disease‐deteriorating genes. These findings foreshadow the potential of TertKI as an extraordinary rejuvenation force, promising not only longevity but also rejuvenation in skin and intestinal aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
- Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia.
- Regenerative Medicine Institute, School of Medicine, University of Galway, Galway, Ireland.
ORCID-Profile: Po Hu
Förderung
- Funding Supporting Projects of National Natural Science Foundation of China of NJUCM
- Natural Science Foundation of the Jiangsu Higher Education Institutions of China
- Open Project of State Key Laboratory of Natural Medicines
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- 2023 Supported by Jiangsu Science and Technology Association Youth Science and Technology Talent Lifting Project
Zitieren
APA
Zhu, T. Y., Hu, P., Mi, Y. H., Zhang, J. L., Xu, A. N., Gao, M. T., Zhang, Y. Y., Shen, S. B., Yang, G. M., & Pan, Y. (2025). Telomerase reverse transcriptase gene knock‐in unleashes enhanced longevity and accelerated damage repair in mice. Aging Cell. https://doi.org/10.1111/acel.14445
Vancouver
Zhu TY, Hu P, Mi YH, Zhang JL, Xu AN, Gao MT, et al. Telomerase reverse transcriptase gene knock‐in unleashes enhanced longevity and accelerated damage repair in mice. Aging Cell. 2025. doi:10.1111/acel.14445
BibTeX
@article{Zhu2025,
author = {Zhu, Tian-Yi and Hu, Po and Mi, Yu-Hui and Zhang, Jun-Li and Xu, An-Na and Gao, Ming-Tong and Zhang, Ying-Ying and Shen, San-Bing and Yang, Guang-Ming and Pan, Yang},
title = {Telomerase reverse transcriptase gene knock‐in unleashes enhanced longevity and accelerated damage repair in mice},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.14445}
}
EUVIMED